{"classes":[{"categories":[{"measurements":[{"groupId":"OG001","spread":"45.9","value":"37.0"},{"groupId":"OG002","spread":"55.4","value":"32.9"},{"groupId":"OG003","spread":"93.8","value":"27.9"},{"groupId":"OG004","spread":"37.5","value":"37.8"},{"groupId":"OG005","spread":"81.0","value":"37.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"5"},{"groupId":"OG004","value":"4"},{"groupId":"OG005","value":"6"}],"units":"Participants"}],"title":"Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"48.3"},{"groupId":"OG001","spread":"73.4","value":"23.5"},{"groupId":"OG002","value":"24.1"},{"groupId":"OG003","spread":"66.4","value":"33.3"},{"groupId":"OG004","value":"37.2"},{"groupId":"OG005","value":"34.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"3"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"1"}],"units":"Participants"}],"title":"Steady State"}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"5"},{"groupId":"OG004","value":"4"},{"groupId":"OG005","value":"6"}],"units":"Participants"}],"description":"Data are reported for evaluable participants.","dispersionType":"Geometric Coefficient of Variation","groups":[{"description":"Concurrent or intermittent dosing of cobimetinib 80 mg, concurrent with GDC-0994 300 mg for 21 consecutive days, followed by 7 days off.","id":"OG000","title":"COB 80 mg + GDC 300 mg"},{"description":"Concurrent or intermittent dosing of cobimetinib 20 mg, concurrent with GDC-0994 200 mg for 21 consecutive days, followed by 7 days off.","id":"OG001","title":"COB 20 mg + GDC 200 mg"},{"description":"Concurrent or intermittent dosing of cobimetinib 40 mg, concurrent with GDC-0994 200 mg for 21 consecutive days, followed by 7 days off.","id":"OG002","title":"COB 40 mg + GDC 200 mg"},{"description":"Concurrent or intermittent dosing of cobimetinib 80 mg, concurrent with GDC-0994 200 mg for 21 consecutive days, followed by 7 days off.","id":"OG003","title":"COB 80 mg + GDC 200 mg"},{"description":"Concurrent or intermittent dosing of cobimetinib 80 mg, concurrent with GDC-0994 400 mg for 21 consecutive days, followed by 7 days off.","id":"OG004","title":"COB 80 mg + GDC 400 mg"},{"description":"Concurrent or intermittent dosing of cobimetinib 100 mg, concurrent with GDC-0994 200 mg for 21 consecutive days, followed by 7 days off.","id":"OG005","title":"COB 100 mg + GDC 200 mg"}],"paramType":"GEOMETRIC_MEAN","populationDescription":"Data are reported for evaluable participants.","reportingStatus":"POSTED","timeFrame":"0 to 24 hours post-dose (Up to Day 22)","title":"Total Exposure (AUC From Time 0 to 24 Hour After Dose) for GDC-0994","type":"SECONDARY","unitOfMeasure":"hr x microM"}